Medical device and MedTech insights, news, tips and more

U.S. Medtech Is Taking Over in Europe

September 22, 2016

U.S. Medtech

When U.S. medtech companies acquire European firms, the deals tend to be worth much more than those of European firms taking over American concerns.

U.S. MedtechThat’s according to a report by EP Vantage, which chalked the imbalance up to the fact that Europeanmedtech companies are generally smaller and less well-funded than their U.S. counterparts. Excluding Medtronic’s $50 billion purchase of Ireland’s Covidien, the biggest U.S. to Europe deals to date include:

In a technically in-Europe deal, Medtronic also agreed in May to buy Smith & Nephew’s gynecology unit for $350 million.

Novartis’ $51.6 billion staged takeover of Alcon, completed in 2010;The top five Europe-to-U.S. deals the service listed for 2010 to 2015 were:

  • Endo International’s purchase of American Medical Systems in 2011;
  • Covidien’s $2.6 billion acquisition of ev3 in 2010;
  • Fresenius’ $1.7 billion of Liberty Dialysis Holdings in 2012;
  • Grifols’ $1.7 billion purchase of Novartis’ blood transfusion business in 2013.

Endo later sold off the urology device business it landed through the American Medical Systems acquisition to Boston Scientific.

Read More: U.S. Medtech Is Taking Over in Europe

Nancy Crotti is a contributor to Qmed.

[Image courtesy of Pixabay]

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.